跳至主要内容
临床试验/JPRN-UMIN000030635
JPRN-UMIN000030635已完成未知

Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study) - Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)

Osaka City University0 个研究点目标入组 3,000 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Participants will be opt-out when the participants and/or their family members do not want to participate in this study upon information disclosure of this study.

研究者

相似试验

招募中
不适用
Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.ormal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndrome
JPRN-UMIN000004946Department of Metabolic Medicine, Faculty of life sciences, Kumamoto University600
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease Hypercholesterolemia
JPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
已完成
不适用
Beneficial effects of cholesterol absorption inhibitor,ezetimibe on impaired endothelial function in patients with metabolic syndrome.Metabolic syndrome
JPRN-UMIN000001305Tohoku University Graduate School of Medicine EZET-trial group60
尚未招募
不适用
Cholesterol Absorption Inhibition Study in humans after single intake of cholesterol lowering margarine, Unilever Study 09030-V, Study name: CASTEmild hypercholesterolemiaslightly elevated cholesterol10013317
NL-OMON34622nilever18
已完成
4 期
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSoundpatients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with &gt=1 significant stenosis &gt=75% and &gt=1 untouched nonculprit lesion of &lt=50% stenosis that could be imaged by intravascular ultrasound, and either LDL-C &gt=100 mg/dl.
JPRN-UMIN000002959Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University300